Herbal medicine for management of the behavioural and psychological symptoms of dementia (BPSD): A systematic review and meta-analysis

• Published in: Journal of Psychopharmacology 2017-02, Vol.31 (2), p.169-183
• Main Authors: Hyde, Anna J, May, Brian H, Dong, Lin, Feng, Mei, Liu, Shaonan, Guo, Xinfeng, Zhang, Anthony Lin, Lu, Chuanjian, Xue, Charlie Changli
• Format: Article
• Language: English
• Subjects: Behavior - drug effects; Cognition - drug effects; Cognitive ability; Dementia; Dementia - drug therapy; Dementia disorders; Geriatric psychology; Ginkgo biloba; Herbal medicine; Herbal Medicine - methods; Humans; Meta-analysis; Neuropsychological Tests; Phytotherapy - methods; Plant Extracts - therapeutic use; Side effects; Systematic review
• ISSN: 0269-8811; 1461-7285
• DOI: 10.1177/0269881116675515

Management of the behavioural and psychological symptoms of dementia remains a challenge worldwide. Herbal medicines may play a role in the development of new interventions. To determine effects of herbal medicines for management of the behavioural and psychological symptoms of dementia, meta-analysis was conducted of 31 controlled trials (3613 participants). Frequently tested herbal medicines were the Ginkgo biloba leaf extract EGb 761 (seven studies) and the multi-ingredient formula Yokukansan (eight studies). Sixteen studies tested other herbal medicines. Improvements were detected in Neuropsychiatric Inventory scores in EGb 761 groups compared to placebo (MD −3.46 [−5.94, −0.98]; I2 = 93%; n = 1757) and Yokukansan groups compared to no treatment (SMD −0.53 [−0.86, −0.21]; I2 = 0%; n = 150). Cognitive scores were improved in EGb 761 groups while Yokukansan did not appear to affect cognitive function. Of the other herbal medicines, there were improvements in the behavioural and psychological symptoms of dementia and cognitive outcomes in two of four placebo-controlled studies. EGb 761 and Yokukansan appeared safe and well tolerated. Adverse effects and dropouts were not reported consistently for the other herbal medicines. Weaknesses of these included short durations, small sample sizes, lack of blinding and other risks of bias. Well-designed studies are needed to further investigate the reported effects of these interventions on the behavioural and psychological symptoms of dementia.